1050 related articles for article (PubMed ID: 31619553)
1. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
2. Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation.
Tedbury PR; Novikova M; Ablan SD; Freed EO
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E182-90. PubMed ID: 26711999
[TBL] [Abstract][Full Text] [Related]
3. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
[TBL] [Abstract][Full Text] [Related]
4. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation.
Eastep GN; Ghanam RH; Green TJ; Saad JS
J Biol Chem; 2021; 296():100321. PubMed ID: 33485964
[TBL] [Abstract][Full Text] [Related]
6. Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.
Alfadhli A; Staubus AO; Tedbury PR; Novikova M; Freed EO; Barklis E
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375589
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation.
Novikova M; Adams LJ; Fontana J; Gres AT; Balasubramaniam M; Winkler DC; Kudchodkar SB; Soheilian F; Sarafianos SG; Steven AC; Freed EO
mBio; 2018 Oct; 9(5):. PubMed ID: 30327442
[TBL] [Abstract][Full Text] [Related]
8. Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure.
Tedbury PR; Ablan SD; Freed EO
PLoS Pathog; 2013; 9(11):e1003739. PubMed ID: 24244165
[TBL] [Abstract][Full Text] [Related]
9. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein.
Manrique JM; Celma CC; Hunter E; Affranchino JL; González SA
J Virol; 2003 Oct; 77(20):10881-8. PubMed ID: 14512538
[TBL] [Abstract][Full Text] [Related]
10. Single-molecule imaging of HIV-1 envelope glycoprotein dynamics and Gag lattice association exposes determinants responsible for virus incorporation.
Pezeshkian N; Groves NS; van Engelenburg SB
Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25269-25277. PubMed ID: 31757854
[TBL] [Abstract][Full Text] [Related]
11. Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein.
Alfadhli A; Romanaggi C; Barklis RL; Barklis E
J Virol; 2024 Feb; 98(2):e0174223. PubMed ID: 38193694
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF
J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 matrix mutations that alter gag membrane binding modulate mature core formation and post-entry events.
Hikichi Y; Takeda E; Fujino M; Nakayama E; Matano T; Murakami T
Virology; 2019 Jun; 532():97-107. PubMed ID: 31055063
[TBL] [Abstract][Full Text] [Related]
14. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
Yu X; Yuan X; Matsuda Z; Lee TH; Essex M
J Virol; 1992 Aug; 66(8):4966-71. PubMed ID: 1629961
[TBL] [Abstract][Full Text] [Related]
15. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
Song YE; Olinger GY; Janaka SK; Johnson MC
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
[TBL] [Abstract][Full Text] [Related]
16. A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles.
Brandano L; Stevenson M
J Virol; 2012 Feb; 86(4):2347-59. PubMed ID: 22156517
[TBL] [Abstract][Full Text] [Related]
17. The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation.
Murphy RE; Saad JS
Viruses; 2020 May; 12(5):. PubMed ID: 32429351
[TBL] [Abstract][Full Text] [Related]
18. A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions.
Qi M; Chu H; Chen X; Choi J; Wen X; Hammonds J; Ding L; Hunter E; Spearman P
Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7575-80. PubMed ID: 26034275
[TBL] [Abstract][Full Text] [Related]
19. Challenging the Existing Model of the Hexameric HIV-1 Gag Lattice and MA Shell Superstructure: Implications for Viral Entry.
Santos JRL; Sun W; Mangukia TA; Reyes-Serratos E; Marcet-Palacios M
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452379
[TBL] [Abstract][Full Text] [Related]
20. Reverted HIV-1 Mutants in CD4
Lu W; Li TW; Phillips S; Wu L
Microbiol Spectr; 2021 Dec; 9(3):e0165321. PubMed ID: 34935422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
